XML 35 R22.htm IDEA: XBRL DOCUMENT
v3.24.3

NET LOSS PER SHARE | 9 Months Ended
--- | ---
Sep. 30, 2024
Earnings Per Share [Abstract] |
NET LOSS PER SHARE | NET LOSS PER SHARE Basic and diluted net loss per share attributable to common stockholders are calculated as follows (in thousands, except share and per share amounts):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Net loss | $ | (992,475) |  |  | $ | (630,894) |  |  | $ | (2,316,724) |  |  | $ | (2,174,654) |
Accretion of redeemable convertible preferred stock (related party) | 42,838 |  |  | — |  |  | (107,924) |  |  | — |
Net loss attributable to common stockholders, basic and diluted | $ | (949,637) |  |  | $ | (630,894) |  |  | $ | (2,424,648) |  |  | $ | (2,174,654) |
Weighted-average shares outstanding attributable to common stockholders, basic and diluted | 2,323,971,541 |  |  | 2,284,446,783 |  |  | 2,312,249,333 |  |  | 2,010,916,100 |
Net loss per share attributable to common stockholders, basic and diluted | $ | (0.41) |  |  | $ | (0.28) |  |  | $ | (1.05) |  |  | $ | (1.08) |
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:
| September 30,
Excluded Securities | 2024 |  | 2023
Private Placement Warrants to purchase common stock | 44,350,000 |  |  | 44,350,000 |
Options outstanding to purchase common stock | 28,845,241 |  |  | 34,320,337 |
RSUs outstanding | 101,501,380 |  |  | 51,817,847 |
Employee stock purchase plan | 16,831,978 |  |  | 9,353,757 |
If-converted common shares from convertible note | 36,737,785 |  |  | 36,737,785 |
If-converted common shares from Series A redeemable convertible preferred stock | 291,019,450 |  |  | — |
If-converted common shares from Series B redeemable convertible preferred stock | 173,206,009 |  |  | — |
Total | 692,491,843 |  |  | 176,579,726 |
The 14,673,053 and 9,452,483 shares of common stock equivalents subject to RSUs are excluded from the anti-dilutive table above as the underlying shares remain contingently issuable since the respective performance conditions have not been satisfied as of September 30, 2024 and 2023, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration